Plasma interleukin-6 levels in Mediterranean spotted fever
J. Oristrell(Corporació Sanitària Parc Taulí), F. Segura(Corporació Sanitària Parc Taulí), Bernat Font(Delft University of Technology), María José Amengual, Moga Sampere(Corporació Sanitària Parc Taulí)
European Journal of Clinical Microbiology & Infectious Diseases
April 21, 2004
Cited by 8
Related Papers
Predictive Factors for Invasive Disease Due to Penicillin-Resistant Streptococcus pneumoniae: A Population-Based Study
|Clinical Infectious Diseases|1994|219
Clinical and Laboratory Characteristics of 144 Patients with Mediterranean Spotted Fever
|European Journal of Clinical Microbiology & Infectious Diseases|2003|212
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
|The Lancet HIV|2020|70
Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever
|Antimicrobial Agents and Chemotherapy|1990|56